Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
12.08. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
05.08. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
21.07. | NSE - IMAC Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 2 | SEC Filings | ||
19.07. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
12.07. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
01.07. | IMAC Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
30.06. | IMAC Holdings, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
30.06. | IMAC Holdings, Inc. - 10-Q/A, Quarterly Report | 1 | SEC Filings | ||
18.06. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
05.06. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
20.05. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
16.05. | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
02.05. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
16.04. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
03.04. | IMAC Holdings, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
31.03. | IMAC Holdings, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
25.03. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
28.01. | Pre-market Movers: IMAC Holdings, Planet Image International, SAB Biotherapeutics, MicroCloud Hologram, Avalon Holdings | 790 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green IMAC Holdings, Inc. (BACK) is up over 91% at $1.59.
Planet... ► Artikel lesen | |
27.01. | IMAC Holdings, Inc.: IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies | 194 | GlobeNewswire (Europe) | Nashville, TN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC Holdings" or the "Company") has launched Ignite Proteomics LLC ("Ignite"), its new subsidiary dedicated to... ► Artikel lesen | |
22.11.24 | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 181 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 0,493 | +9,54 % | Plus Therapeutics stock rating upgraded to Buy by D. Boral Capital | ||
LIFEWARD | 0,532 | -4,44 % | Lifeward Ltd.: Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
EKSO BIONICS | 3,990 | -1,72 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 4,740 | -3,66 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
ROCKWELL MEDICAL | 1,464 | +6,16 % | ROCKWELL MEDICAL, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
VIRIDIAN THERAPEUTICS | 15,620 | -2,25 % | These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results | ||
SINTX TECHNOLOGIES | 5,500 | +25,57 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
AETHLON MEDICAL | 1,430 | -100,00 % | Aethlon Medical Prices $4.5 Mln Public Offering Of Common Stock And Warrants | ||
STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
NEURONETICS | 2,725 | -1,09 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
HVIVO | 0,096 | 0,00 % | hVIVO PLC - Notice of Results | ||
FRESENIUS | 46,820 | -0,76 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Fresenius von 49 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Die Phase steigender Markterwartungen sei bei... ► Artikel lesen |